RxSight, Inc. to Present at the SVB Leerink Global Healthcare Conference
RxSight, Inc., an ophthalmic medical device company based in Aliso Viejo, California, has announced participation in the SVB Leerink Global Healthcare Conference.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
RxSight, Inc., an ophthalmic medical device company based in Aliso Viejo, California, has announced participation in the SVB Leerink Global Healthcare Conference. Management will join a fireside chat on February 17, 2022, at 12:40 PM PT / 3:40 PM ET. Interested audiences can access the live or archived webcast via the company's investor section. RxSight is recognized for its innovative Light Adjustable Lens system, which allows customization of visual acuity post-cataract surgery, now enhanced with ActivShield technology for UV protection.
Details
News Market Reaction – RXST
The recorded move for RXST in the trading session of this news was +0.09%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
ALISO VIEJO, Calif., Feb. 03, 2022 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming virtual SVB Leerink Global Healthcare Conference.
RxSight’s management is scheduled to participate in a fireside chat Thursday, February 17, 2022, at 12:40pm PT / 3:40pm ET. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company’s website at: https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL®), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The LAL now features ActivShield™ technology, a revolutionary UV protection layer built into the lens. Additional information about RxSight can be found at www.rxsight.com.
Investor Relations Contact:
Philip Taylor
Gilmartin Group
415.937.5406
IR@rxsight.com
Company Contact:
Shelley Thunen
RxSight, Inc.
949-521-7830
IR@rxsight.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.